Weil M - Search Results

1

A survey of the anthracycline derivatives in hematology.

Jacquillat C, Weil M, Auclerc MF, Maral J, Schaison G, Boiron M, Bernard J. Jacquillat C, et al. Among authors: weil m. Cancer Chemother Pharmacol. 1979;2(1):53-9. doi: 10.1007/BF00253106. Cancer Chemother Pharmacol. 1979. PMID: 498421 No abstract available.

2

Prognosis and treatment of acute lymphoblastic leukemia. Study of 650 patients.

Jacquillat C, Weil M, Auclerc MF, Chastang C, Flandrin G, Izrael V, Schaison G, Degos L, Boiron M, Bernard J. Jacquillat C, et al. Among authors: weil m. Cancer Chemother Pharmacol. 1978;1(2):113-22. doi: 10.1007/BF00254045. Cancer Chemother Pharmacol. 1978. PMID: 373912 Clinical Trial.

3

Clinical activity of detorubicin: a new anthracycline derivative.

Jacquillat C, Auclerc MF, Weil M, Maral J, Degos L, Auclerc G, Tobelem G, Schaison G, Bernard J. Jacquillat C, et al. Among authors: weil m. Cancer Treat Rep. 1979 May;63(5):889-93. Cancer Treat Rep. 1979. PMID: 455330

4

Features and prognosis of chemotherapy-treated Hodgkin's disease with initial bone marrow involvement.

Auclerc G, Auclerc MF, Weil M, Andrieu JM, Jacquillat C, Bernard J. Auclerc G, et al. Among authors: weil m. Cancer Chemother Pharmacol. 1979;2(3):189-96. doi: 10.1007/BF00258294. Cancer Chemother Pharmacol. 1979. PMID: 455574

5

[Survey of anthracyclines derivatives in haematology (author's transl)].

Jacquillat C, Weil M, Auclerc MF, Maral J, Schaison G, Boiron M, Bernard J. Jacquillat C, et al. Among authors: weil m. Nouv Presse Med. 1978 Jun 10;7(23):2061-6. Nouv Presse Med. 1978. PMID: 673774 French.

6

Experimental and clinical activity of a new anthracycline derivative: detorubicin (14-diethoxyacetoxydaunorubicin).

Maral R, Heusse D, Lavelle F, Cueille G, Marlard M, Jacquillat C, Maral J, Auclerc MF, Weil M, Auclerc G, Bernard J. Maral R, et al. Among authors: weil m. Recent Results Cancer Res. 1980;74:172-83. doi: 10.1007/978-3-642-81488-4_22. Recent Results Cancer Res. 1980. PMID: 7444138

7

Post-therapeutic acute leukemia.

Auclerc G, Jacquillat C, Auclerc MF, Weil M, Bernard J. Auclerc G, et al. Among authors: weil m. Cancer. 1979 Dec;44(6):2017-25. doi: 10.1002/1097-0142(197912)44:6<2017::aid-cncr2820440609>3.0.co;2-a. Cancer. 1979. PMID: 389405 Review.

8

Clinical study of rubidazone (22 050 R.P.), a new daunorubicin-derived compound, in 170 patients with acute leukemias and other malignancies.

Jacquillat C, Weil M, Gemon-Auclerc MF, Izrael V, Bussel A, Boiron M, Bernard J. Jacquillat C, et al. Among authors: weil m. Cancer. 1976 Feb;37(2):653-9. doi: 10.1002/1097-0142(197602)37:2<653::aid-cncr2820370207>3.0.co;2-q. Cancer. 1976. PMID: 1062226

9

High risk acute lymphocytic leukemia: a study of 141 cases with initial white blood cell counts over 100,000/cu mm.

Harousseau JL, Tobelem G, Schaison G, Chastang C, Auclerc MF, Weil M, Jacquillat C, Bernard J. Harousseau JL, et al. Among authors: weil m. Cancer. 1980 Nov 1;46(9):1996-2003. doi: 10.1002/1097-0142(19801101)46:9<1996::aid-cncr2820460917>3.0.co;2-r. Cancer. 1980. PMID: 6932999

10

Adjuvant chemotherapy in the management of primary malignant melanoma.

Banzet P, Jacquillat C, Civatte J, Puissant A, Maral J, Chastang C, Israel L, Belaich S, Jourdain JC, Weil M, Auclerc G. Banzet P, et al. Among authors: weil m. Cancer. 1978 Apr;41(4):1240-8. doi: 10.1002/1097-0142(197804)41:4<1240::aid-cncr2820410404>3.0.co;2-j. Cancer. 1978. PMID: 346192 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,304 results

Search Page

Filters